Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schubert-Zsilavecz

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Pharmazie in Unserer Zeit|January 4, 2011
[Message from the President]Manfred Schubert-Zsilavecz
Krankenpflege Journal|March 7, 2006
[Cutaneous administration rather than swallowing]Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|September 7, 2010
[Treatment of erectile dysfunction]Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|June 6, 2003
[Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison]Mario Wurglics, Manfred Schubert-Zsilavecz
Molecules (Basel, Switzerland)|December 7, 2011
Tertiary alkylamines as nucleophiles in substitution reactions at heteroaromatic halide during the synthesis of the highly potent pirinixic acid derivative 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS-121)Matthias Gabler, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|September 7, 2010
[ Editorial. Pharmazie in unserer Zeit 5/2010]Theo Dingermann, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|March 3, 2010
[New classes of drugs in the pipeline. New in the treatment of diabetes mellitus]Ramona Steri, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|December 4, 2003
[Regarding public health there is no doubt that in Germany and Europe that it is driven by economic considerations]Walter Schunack, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|July 12, 2008
[High-throughput screening for inhibitors of bacterial transglycosylase]Ramona Steri, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|October 29, 2008
[Liebe Kolleginnen und Kollegen]Holger Stark, Manfred Schubert-Zsilavecz
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Pharmazie in Unserer Zeit|January 4, 2011
[Message from the President]Manfred Schubert-Zsilavecz
Krankenpflege Journal|March 7, 2006
[Cutaneous administration rather than swallowing]Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|September 7, 2010
[Treatment of erectile dysfunction]Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|June 6, 2003
[Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison]Mario Wurglics, Manfred Schubert-Zsilavecz
Molecules (Basel, Switzerland)|December 7, 2011
Tertiary alkylamines as nucleophiles in substitution reactions at heteroaromatic halide during the synthesis of the highly potent pirinixic acid derivative 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS-121)Matthias Gabler, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|September 7, 2010
[ Editorial. Pharmazie in unserer Zeit 5/2010]Theo Dingermann, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|March 3, 2010
[New classes of drugs in the pipeline. New in the treatment of diabetes mellitus]Ramona Steri, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|December 4, 2003
[Regarding public health there is no doubt that in Germany and Europe that it is driven by economic considerations]Walter Schunack, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|July 12, 2008
[High-throughput screening for inhibitors of bacterial transglycosylase]Ramona Steri, Manfred Schubert-Zsilavecz
Pharmazie in Unserer Zeit|October 29, 2008
[Liebe Kolleginnen und Kollegen]Holger Stark, Manfred Schubert-Zsilavecz
Pageof 20